Call Start: 16:30 January 1, 0000 4:51 PM ET
Biotricity, Inc. (OTC:BTCY)
Q2 2025 Earnings Conference Call
November 15, 2024, 4:30 PM ET
Company Participants
Dr. Waqaas Al-Siddiq – Founder and CEO
John Ayanoglou – Chief Financial Officer
Conference Call Participants
Michael Davin – H.C. Wainwright
Operator
Greetings. And welcome to the Biotricity Conference Call. At this time, all participants are in a listen-only mode. The question-and-answer session will follow the formal presentation. [Operator Instructions]
As a reminder, this conference is being recorded. It is now my pleasure to introduce Founder and CEO, Dr. Waqaas Al-Siddiq. Thank you. You may begin.
Dr. Waqaas Al-Siddiq
Thank you everybody for joining us today. Second quarter 2025 has been a transformative quarter for Biotricity marked by significant advancements and strategic initiatives that has led to us achieving positive EBITDA for the first time in September and continue our path to profitability. One of our most significant achievements this quarter has been the improvement in all aspects of the business from revenues to margins, operational efficiency and a shift to positive EBITDA.
Our commitment to innovation, strategic partnerships and operational efficiency has allowed us to make remarkable progress across multiple fronts. We are continuing to expand our Cardiac AI Cloud capabilities harnessing our data to explore predictive capabilities with our platform. Recently, we published our research in predicting postoperative complications in Nature. We expect to expand our research and file for FDA of our AI clinical model by mid next year.
Our recent strategic alliances with the top group purchasing organizations, otherwise known as GPOs and specialist organizations in neurology and pulmonology are beginning to gain momentum. These partnerships have helped kick off multiple large opportunities that are currently in pilots along with expanding our reach beyond cardiology, significantly expanding our market reach. This positions us to capitalize
Read the full article here
